Works by Masson, D.


Results: 68
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas1-, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    24

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas1-, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    25

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study. .

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    26

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    27

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    28

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 37, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    29

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    30

    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.252791
    By:
    • Bodet-Milin, C.;
    • Faivre-Chauvet, A.;
    • Carlier, T.;
    • Ansquer, C.;
    • Rauscher, A.;
    • Frampas, E.;
    • Toulgoat, F.;
    • Masson, D.;
    • Bourgeois, M.;
    • Cerato, E.;
    • Rohmer, V.;
    • Couturier, O.;
    • Drui, D.;
    • Goldenberg, D. M.;
    • Sharkey, R. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.
    Publication type:
    Article
    31
    32

    Quality of Turkey Oak (Quercus cerris L.) Wood.

    Published in:
    Holzforschung: International Journal of the Biology, Chemistry, Physics, & Technology of Wood, 1991, v. 45, n. 4, p. 291
    By:
    • Lavisci, P.;
    • Scalbert, A.;
    • Masson, D.;
    • Janin, G.
    Publication type:
    Article
    33
    34

    Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 874, doi. 10.1007/s00259-020-04989-3
    By:
    • Touchefeu, Y.;
    • Bailly, C.;
    • Frampas, E.;
    • Eugène, T.;
    • Rousseau, C.;
    • Bourgeois, M.;
    • Bossard, C.;
    • Faivre-Chauvet, A.;
    • Rauscher, A.;
    • Masson, D.;
    • David, A.;
    • Cerato, E.;
    • Carlier, T.;
    • Sharkey, R. M.;
    • Goldenberg, D. M.;
    • Barbet, J.;
    • Kraeber-Bodere, F.;
    • Bodet-Milin, C.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Unusual “Hyperparathyroidism”.

    Published in:
    Clinical Chemistry, 2017, v. 63, n. 2, p. 617, doi. 10.1373/clinchem.2016.264499
    By:
    • Outtier, A. S.;
    • Bras, M. Le;
    • Lerat, F.;
    • Masson, D.;
    • Bach-Ngohou, K.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50